Filings & corporate actions
- 4 AugresultsResults · Q1 FY27 · consolidated and standalone+5.6%NSE
- 7 JulshareholdingShareholding · 30 Jun 2026-1.8%NSE
- 21 MayresultsResults · Q4 FY26 · consolidated and standalone-0.4%NSE
- 13 AprshareholdingShareholding · 31 Mar 2026-0.6%NSE
- 3 FebresultsResults · Q3 FY26 · consolidated and standalone+1.0%NSE
- 20 JanshareholdingShareholding · 31 Dec 2025-1.7%NSE
Reaction to results · all yearsrose on day 0 in 3 of 7 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q1 FY27 | 4 Aug 2026 | +5.6% | +3.6% | +4.2% | 6.8× |
| Q4 FY26 | 21 May 2026 | -0.4% | +0.1% | -1.8% | 2.5× |
| Q3 FY26 | 3 Feb 2026 | +1.0% | +2.7% | -0.2% | 0.6× |
| Q2 FY26 | 30 Oct 2025 | -2.4% | -3.0% | +2.8% | 1.5× |
| Q1 FY26 | 12 Aug 2025 | +0.4% | +1.3% | -3.6% | 1.0× |
| Q4 FY25 | 29 May 2025 | -1.6% | +0.5% | +13.3% | 1.5× |
| Q3 FY25 | 15 Feb 2025 | -3.3% | -8.3% | -4.9% | — |
| Average | -0.1% | -0.5% | +1.4% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth · Q1 FY27
CSV| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Profit | — | — | — | — | — | — |
Key data
CSVDelivery percentage
Over the last 20 sessions AGARWALEYE settled 56.5% of its traded quantity, which is above average for an NSE equity. Its one-year average is 49.3%, so recent sessions are running 7.3 points higher than usual. The latest session ranks higher than 50% of the 412 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
Performance returns
CSV| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | +0.54% | -3.33% | -4.81% | +3.03% | +16.75% | -0.40% |
Valuation
CSVOwnership
CSVQuarterly results · consolidated
CSV| Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|
| Revenue (₹ Cr) | 498.7 | 529.9 | 564.1 | 614.0 |
| YoY chg | — | +23.0% | +22.6% | +26.0% |
| Net profit (₹ Cr) | 36.5 | 43.6 | 50.0 | 55.0 |
| YoY chg | — | +54.5% | +17.4% | +44.6% |
| Net margin | 7.3% | 8.2% | 8.9% | 9.0% |
| EPS | 0.93 | 1.06 | 1.24 | 1.42 |
Shareholding over time
CSVBy quarter
30 Jun 2026 · promoter 32.34% · public 67.66%- Promoter
- Public and others
- Promoter
- 32.34%
- Public
- 67.66%
- Promoter change
- -0.02 pp
- Filed
- 7 Jul 2026
- FII
- 57.96%
- DII
- 7.72%
- Promoter pledged
- 0.00%
Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.
Financials · quarterly statement
CSV| Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26A | Q1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 430.7 | 460.2 | 487.4 | 498.7 | 529.9 | 564.1 | 614.0 | |
| Other income | 12.7 | 15.4 | 13.4 | 7.9 | 10.5 | 12.6 | 6.4 | |
| Total income | 443.4 | 475.7 | 500.8 | 506.6 | 540.4 | 576.7 | 620.4 | |
| Total expenses | 402.4 | 414.6 | 447.2 | 453.0 | 475.6 | 501.4 | 545.3 | |
| └ Finance costs | 28.4 | 25.0 | 24.7 | 22.6 | 21.1 | 22.1 | 23.4 | |
| └ Depreciation | 58.2 | 60.4 | 63.0 | 67.9 | 68.8 | 76.7 | 78.3 | |
| Profit before tax | 41.0 | 58.5 | 53.6 | 53.7 | 64.8 | 76.6 | 75.1 | |
| Tax expense | 12.8 | 16.0 | 15.5 | 17.2 | 21.1 | 26.7 | 20.1 | |
| Net profit | 28.2 | 42.6 | 38.1 | 36.5 | 43.6 | 50.0 | 55.0 | |
| EPS | 0.73 | 1.04 | 0.95 | 0.94 | 1.07 | 1.25 | 1.43 | |
| Net margin | 6.56% | 9.25% | 7.81% | 7.32% | 8.23% | 8.86% | 8.96% | |
| PBT margin | 9.52% | 12.72% | 11.00% | 10.76% | 12.22% | 13.58% | 12.24% | |
| Tax rate | 31.11% | 27.29% | 28.99% | 32.00% | 32.63% | 34.80% | 26.78% |
A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 4 Aug 2026.
AGARWALEYE at a glance
- AGARWALEYE closed at ₹486.85 on 6 Oct 2026, +0.54% on the day, -0.4% over one year, 14.3% below its 52-week high of ₹568.
- Delivery was 49.3% of traded quantity on 6 Oct 2026, the 50th percentile of its own 412 sessions with a reading (20-session average 56.5%, 1-year average 49.3%).
- Market capitalisation is ₹15,434 crore at a trailing P/E of 83.4 (trailing EPS ₹5.84).
- Q1 FY27 results (consolidated, filed 4 Aug 2026): revenue ₹614 crore (+26.0% year on year), net profit ₹55 crore (+44.6%); the price moved +5.6% on the first session after.
- Promoters held 32.34% at 30 Jun 2026, down 0.02 percentage points on the previous filing.
- Q2 FY27 results are expected between 30 Oct 2026 and 28 Nov 2026, going by past filing dates — an estimate, not an announcement.
About
CSVPrices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.
More in Healthcare Services
CSV- APOLLOHOSPApollo Hospitals Enterprise Limited7,914.50-0.88%
- MAXHEALTHMax Healthcare Institute Limited902.50-1.58%
- FORTISFortis Healthcare Limited764.00+0.03%
- YATHARTHYatharth Hospital & Trauma Care Services Limited1,058.80+5.56%
- ASTERDMAster DM Quality Care Limited684.70-0.98%
- MANIPALHOSManipal Health Enterprises Limited690.50+3.52%
- LALPATHLABDr. Lal Path Labs Ltd.1,964.20-0.36%
- ARTEMISMEDArtemis Medicare Services Limited318.35-1.77%
- NEPHROPLUSNephrocare Health Services Limited634.55-0.49%
- GKSLGujarat Kidney And Super Speciality Limited193.62+1.72%
- KIMSKrishna Institute of Medical Sciences Limited693.40-1.71%
- NHNarayana Hrudayalaya Ltd.1,723.80+0.08%
All Healthcare Services stocks on the NSEAll Healthcare stocks on the NSE